MedTrace Logo

The Effect of a Probiotic on Upper Respiratory Tract Infections

NCT03636191 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 619

Last updated 2020-07-10

No results posted yet for this study

Summary

This study is a randomized, double-blind, placebo-controlled, two-armed, parallel-group study in healthy children aged 2-6 years. The study will investigate the effect of daily intake of a probiotic on Upper Respiratory Tract Infections (URTI) during a 16-week intervention.

Conditions

  • Infections, Upper Respiratory Tract

Interventions

DIETARY_SUPPLEMENT

Probiotic strain

Lactobacillus

DIETARY_SUPPLEMENT

Placebo

Placebo

Sponsors & Collaborators

  • Onorach Clinical

    collaborator UNKNOWN

  • CPS Research

    collaborator UNKNOWN

  • Chr Hansen

    lead INDUSTRY

Principal Investigators

  • Gordon Crawford, DRCOG · CPS Research

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2019-04-13
Completion
2019-08-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03636191 on ClinicalTrials.gov